Literature DB >> 26880146

Schizophrenia as a prodromal symptom in a patient harboring SNCA duplication.

Shogo Takamura1, Aya Ikeda2, Kenya Nishioka2, Hirokazu Furuya3, Mari Tashiro4, Takashi Matsushima2, Yuanzhe Li2, Hiroyo Yoshino5, Manabu Funayama6, Shigeru Morinobu1, Nobutaka Hattori7.   

Abstract

We present the case of a patient who developed delusions and auditory hallucinations and was clinically diagnosed as having schizophrenia. Ten years after the onset of schizophrenia, the disease progressed to mild parkinsonism. SNCA duplication was confirmed. This case expands the spectrum of clinical features in carriers of SNCA duplication.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dementia with Lewy bodies; Parkinson's disease; Psychosis; SNCA duplication; Schizophrenia

Mesh:

Substances:

Year:  2016        PMID: 26880146     DOI: 10.1016/j.parkreldis.2016.01.028

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

Review 1.  α-Synuclein and Parkinsonism: Updates and Future Perspectives.

Authors:  Kaie Rosborough; Neha Patel; Lorraine V Kalia
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

2.  Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson's Disease.

Authors:  Asako Yoritaka; Tetsuo Hayashi; Keiko Fusegi; Rie Inami; Nobutaka Hattori
Journal:  Parkinsons Dis       Date:  2022-05-26

Review 3.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

Review 4.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

5.  A population scale analysis of rare SNCA variation in the UK Biobank.

Authors:  Cornelis Blauwendraat; Mary B Makarious; Hampton L Leonard; Sara Bandres-Ciga; Hirotaka Iwaki; Mike A Nalls; Alastair J Noyce; Andrew B Singleton
Journal:  Neurobiol Dis       Date:  2020-12-08       Impact factor: 5.996

6.  HERV-W Envelope Triggers Abnormal Dopaminergic Neuron Process through DRD2/PP2A/AKT1/GSK3 for Schizophrenia Risk.

Authors:  Qiujin Yan; Xiulin Wu; Ping Zhou; Yan Zhou; Xuhang Li; Zhongchun Liu; Huawei Tan; Wei Yao; Yaru Xia; Fan Zhu
Journal:  Viruses       Date:  2022-01-14       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.